Neurocrine Biosciences (Brazil) Price Prediction
| N1BI34 Stock | 36.16 0.49 1.37% |
Oversold Vs Overbought
65
Oversold | Overbought |
Using Neurocrine Biosciences hype-based prediction, you can estimate the value of Neurocrine Biosciences from the perspective of Neurocrine Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Neurocrine Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Neurocrine because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Neurocrine Biosciences after-hype prediction price | BRL 36.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neurocrine |
Neurocrine Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Neurocrine Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neurocrine Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neurocrine Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neurocrine Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Neurocrine Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neurocrine Biosciences' historical news coverage. Neurocrine Biosciences' after-hype downside and upside margins for the prediction period are 33.27 and 39.05, respectively. We have considered Neurocrine Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neurocrine Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Neurocrine Biosciences is based on 3 months time horizon.
Neurocrine Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Neurocrine Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neurocrine Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neurocrine Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 2.89 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
36.16 | 36.16 | 0.00 |
|
Neurocrine Biosciences Hype Timeline
Neurocrine Biosciences is now traded for 36.16on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neurocrine is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.19%. %. The volatility of related hype on Neurocrine Biosciences is about 0.0%, with the expected price after the next announcement by competition of 36.16. The company had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Neurocrine Biosciences Basic Forecasting Models to cross-verify your projections. For information on how to trade Neurocrine Stock refer to our How to Trade Neurocrine Stock guide.Neurocrine Biosciences Related Hype Analysis
Having access to credible news sources related to Neurocrine Biosciences' direct competition is more important than ever and may enhance your ability to predict Neurocrine Biosciences' future price movements. Getting to know how Neurocrine Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neurocrine Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CVSH34 | CVS Health | 0.00 | 0 per month | 2.66 | (0.01) | 3.44 | (3.90) | 23.09 | |
| P1EA34 | Healthpeak Properties | 0.00 | 0 per month | 0.78 | 0.04 | 2.19 | (2.06) | 9.00 | |
| S1IV34 | SVB Financial Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| S1MF34 | Sumitomo Mitsui Financial | 0.00 | 0 per month | 1.34 | 0.1 | 3.80 | (3.16) | 13.50 | |
| HOME34 | The Home Depot | 0.00 | 0 per month | 1.63 | 0.08 | 2.51 | (2.20) | 18.08 | |
| CAON34 | Capital One Financial | 0.00 | 0 per month | 0.00 | 0.16 | 5.98 | (1.04) | 14.13 | |
| CRDA34 | Credit Acceptance | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CHCM34 | Charter Communications | 0.00 | 0 per month | 1.60 | 0.06 | 4.23 | (3.11) | 17.68 |
Neurocrine Biosciences Additional Predictive Modules
Most predictive techniques to examine Neurocrine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurocrine using various technical indicators. When you analyze Neurocrine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neurocrine Biosciences Predictive Indicators
The successful prediction of Neurocrine Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neurocrine Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neurocrine Biosciences based on analysis of Neurocrine Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neurocrine Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neurocrine Biosciences's related companies.
Story Coverage note for Neurocrine Biosciences
The number of cover stories for Neurocrine Biosciences depends on current market conditions and Neurocrine Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neurocrine Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neurocrine Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Neurocrine Biosciences Short Properties
Neurocrine Biosciences' future price predictability will typically decrease when Neurocrine Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neurocrine Biosciences often depends not only on the future outlook of the potential Neurocrine Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neurocrine Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 94.9 M |
Complementary Tools for Neurocrine Stock analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |